Aquestive therapeutics announces expert allergy scientific advisory board

Warren, n.j., sept. 12, 2022 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, announced today the establishment of a scientific advisory board comprised of eight allergy experts.
AQST Ratings Summary
AQST Quant Ranking